EUVIMEDОткрийте EUVIMED
Open access · CC BY 4.0

Curcumin enhances GSDME-mediated pyroptosis to potentiate PD-1/PD-L1 immune checkpoint blockade in colorectal cancer

Dongsheng Tan, Gengdong Li, Xiaoda Li, Weiwei Zhai, Lijia Jing

Frontiers in Pharmacology · 2026-02-02 · 17

DOI: 10.3389/fphar.2026.1734653 ↗

At a glance

Journal article in Frontiers in Pharmacology, published online on 2026-02-02. Written by Dongsheng Tan and 4 co-authors. Institution: College of Life Science, Northeast Forestry University, Harbin, China. Cited 8 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0).

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Colorectal cancer (CRC) patients with a microsatellite-stable (MSS) status exhibit poor responsiveness to PD-1/PD-L1 blockade. Pyroptosis induction may resensitize MSS tumors to PD-1/PD-L1 blockade; however, the expression of GSDME, a key executor of pyroptosis, is often downregulated in CRC. Here, curcumin (CUR), a natural polyphenol, was identified as a potentiator of GSDME-dependent pyroptosis in CRC. We discovered that CUR upregulates GSDME expression by inhibiting the ubiquitin–proteasome system (UPS) in the MSS-type CT26 and HT29 cell lines and activating the caspase-3/GSDME signalling axis, resulting in increased pyroptosis. In CT26 tumors, CUR-enhanced pyroptosis reshaped tumor-infiltrating immune subsets and potentiated the efficacy of anti–PD-1 therapy. Notably, the synergistic antitumor activity of CUR combined with PD-1 blockade in CT26 tumors is strictly dependent on the caspase-3/GSDME axis, as the therapeutic benefit was abolished in GSDME-knockout tumors. These findings establish CUR as a safe and effective adjuvant for PD-1/PD-L1 blockade in MSS CRC, particularly in tumors with low GSDME expression.

Subjects

Author keywords

GSDMEcolorectal cancercurcuminimmune checkpointtherapypyroptosis

Authors and institutions

  • College of Life Science, Northeast Forestry University, Harbin, China.
  • Jiangsu Food and Pharmaceutical Science College, Huaian, China.
  • Peking University Health Science Center, Beijing, China.
  • Jiangsu Engineering Research Center for Precision Health Medicated Food Product Development and Processing Technology, Huaian, China.

Cite

APA

Tan, D., Li, G., Li, X., Zhai, W., & Jing, L. (2026). Curcumin enhances GSDME-mediated pyroptosis to potentiate PD-1/PD-L1 immune checkpoint blockade in colorectal cancer. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1734653

Vancouver

Tan D, Li G, Li X, Zhai W, Jing L. Curcumin enhances GSDME-mediated pyroptosis to potentiate PD-1/PD-L1 immune checkpoint blockade in colorectal cancer. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1734653

BibTeX
@article{Tan2026,
  author = {Tan, Dongsheng and Li, Gengdong and Li, Xiaoda and Zhai, Weiwei and Jing, Lijia},
  title = {Curcumin enhances GSDME-mediated pyroptosis to potentiate PD-1/PD-L1 immune checkpoint blockade in colorectal cancer},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1734653}
}
Start for free →